Deferasirox [deferasirox]
topical
7
- Terms
-
Exjade
-
4-(3,5-Bis-(2-hydroxyphenyl)-(1,2,4)-triazol-1-yl)benzoic acid
Exjade
ICL 670
ICL 670A
ICL-670
ICL-670A
ICL670
ICL670A
Persistent link
https://www.medvik.cz/link/D000077588
Definition
A triazole and benzoate derivative that acts as a selective iron chelator. It is used in the management of chronic IRON OVERLOAD due to blood transfusion or non-transfusion dependent THALASSEMIA.
- DUI
- D000077588 MeSH Browser
- CUI
- M0490722
- History note
- 2019 (2000)
- Public note
- 2019; DEFERASIROX was indexed under BENZOATES and TRIAZOLES 2000-2018
Allowable subheadings
- AD
- administration & dosage 2
- AE
- adverse effects 1
- AG
- agonists
- AA
- analogs & derivatives
- AN
- analysis
- AI
- antagonists & inhibitors
- BL
- blood
- CF
- cerebrospinal fluid
- CS
- chemical synthesis
- CH
- chemistry
- CL
- classification
- EC
- economics
- HI
- history
- IM
- immunology
- IP
- isolation & purification
- ME
- metabolism
- PK
- pharmacokinetics
- PD
- pharmacology 2
- PO
- poisoning
- RE
- radiation effects
- ST
- standards
- SD
- supply & distribution
- TU
- therapeutic use
- TO
- toxicity
- UR
- urine
...
Occurrences in Medvik records
D
Chemicals and Drugs
D02.241.223.100.141
Benzoylcholine
D02.241.223.100.150
Bromobenzoates
D02.241.223.100.500
Mercuribenzoates
D02.455.426.559.389.127.141
Benzoylcholine
D02.455.426.559.389.127.150
Bromobenzoates
D02.455.426.559.389.127.500
Mercuribenzoates
D03.383.129.799.500
Guanazole
D03.383.129.799.900
Trapidil